Harlow, United Kingdom

Alister Campbell


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Alister Campbell: Innovator in Pharmaceutical Chemistry

Introduction

Alister Campbell is a notable inventor based in Harlow, GB, who has made significant contributions to the field of pharmaceutical chemistry. With a portfolio of three patents, he has developed innovative compounds that have potential therapeutic applications. His work focuses primarily on piperazine derivatives that play a crucial role in modulating calcium channels.

Latest Patents

Alister Campbell's latest patents include the development of 3-pyridylcarbonyl-piperazinylsulfonyl derivatives. This invention relates to novel piperazine derivatives, detailing processes for their preparation, pharmaceutical compositions containing these derivatives, and their use in treating diseases where blocking the Ca2.2 calcium channels is beneficial. Additionally, he has patented piperazine derivatives used as CAV2.2 calcium channel modulators, emphasizing similar therapeutic applications and preparation processes.

Career Highlights

Alister has made his mark in the pharmaceutical industry while working at Convergence Pharmaceuticals Limited. His innovative approaches to drug development highlight his commitment to improving therapeutic options for various medical conditions. His ability to translate complex chemical processes into practical applications is a testament to his expertise and dedication.

Collaborations

Throughout his career, Alister Campbell has collaborated with esteemed colleagues such as Paul John Beswick and Andrew Peter Cridland. These partnerships have not only contributed to his innovative projects but have also fostered a collaborative environment conducive to the advancement of pharmaceutical research.

Conclusion

In conclusion, Alister Campbell stands out as a prominent inventor in the pharmaceutical field, having developed key piperazine derivatives that expand treatment options for diseases linked to calcium channel dysfunction. His work showcases the importance of innovation and collaboration in advancing medical science, making significant strides toward improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…